BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 11/09/2018

FDA Publishes Draft Guidance on Postapproval Changes to Drug Substances

The FDA has released a draft guidance for industry outlining recommendations for making changes to drug substance manufacturing processes during the postapproval period for approved pharmaceutical products.

Source: Federal Register — Food and Drug AdministrationOpen original release →